FDA approves first follow-on short-acting insulin product using abbreviated approval pathwayDecember 12, 2017Diabetes
Seven years after bariatric surgery, more than 40% still off insulinNovember 4, 2017DiabetesObesityLipid Disorders
CV outcomes better with SGLT2 inhibitor than DPP4 inhibitor in T2DM studyNovember 4, 2017DiabetesLipid Disorders
